QURE Stock Analysis: Buy, Sell, or Hold?
QURE - uniQure N.V.
$43.83
-0.23 (-0.52%)
▼
5d:
+19.56%
30d:
+5.97%
90d:
+111.94%
BUY
HIGH Confidence
Analysis Updated: Aug 3, 2026 12:00 AM ET
Earnings: Jul 29, 2026
0d
Smart Money Accumulation
None View Scanner →
Strength: 5.8/10
Get Alerted When QURE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: QURE shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: QURE shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: QURE is currently trading at $43.83, which is considered fair relative to its 30-day fair value range of $39.24 to $45.95.
Technical Outlook: Technically, QURE is in a strong uptrend. The price is approaching resistance at $44.99. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: QURE has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $68.16 (+54.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, QURE is in a strong uptrend. The price is approaching resistance at $44.99. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: QURE has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $68.16 (+54.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$39.24 -
$45.95
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
86.8%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 54.7% below Wall St target ($68.16)
Trading Range Analysis
30-Day Trading Range
$39.24 -
$45.95
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$35.34
Resistance Level
$44.99
Current Trend
Strong Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-17.30
Wall Street Target
$68.16
(+54.7%)
Revenue Growth (YoY)
11.0%
Earnings Growth (YoY)
-18.2%
Share & Embed Analysis
Last updated: August 04, 2026 11:31 AM ET
Data refreshes hourly during market hours. Next update: 12:31 PM
Data refreshes hourly during market hours. Next update: 12:31 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is QURE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Jeannette Potts
SELL
3412 shares
2026-03-04
Matthew C Kapusta
SELL
14581 shares
2026-03-04
Walid Abi-Saab
SELL
808 shares
2026-03-04
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$89 | 59 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 56 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 53 HOLD |
|
ARVN
Arvinas Inc |
BUY
21 analysts |
$15 | 51 HOLD |
Advanced QURE Option Strategies
Professional options setups generated by AI based on today's QURE price and gamma walls.
